Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Gynecol Oncol. 2015 Sep 14;139(2):228–235. doi: 10.1016/j.ygyno.2015.09.011

Figure 3.

Figure 3

Progression-free survival as a function of an initial disease-free (DF) state or never disease-free state (NDF) (A). The effect of DF or NDF states on later treatment-free intervals (TFI) (B); the sample size reflects the number of unique intervals with DF/NDF information. The duration of TFI as a function of the number of previous lines of therapy (C). Platinum treatment efficacy as a function of the previous platinum interval (D).